Is it time to adopt angiotensin receptor-neprilysin inhibitors (ARNI) therapy as standard of care for the management of hypertension?
@article{APM103463, author = {Ayan Ali and Juan M. Ortega-Legaspi}, title = {Is it time to adopt angiotensin receptor-neprilysin inhibitors (ARNI) therapy as standard of care for the management of hypertension?}, journal = {Annals of Palliative Medicine}, volume = {11}, number = {10}, year = {2022}, keywords = {}, abstract = {}, issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/103463} }